ZANTAC EFFERDOSE Trademark

Trademark Overview

On Friday, October 28, 2011, a trademark application was filed for ZANTAC EFFERDOSE with the United States Patent and Trademark Office. The USPTO has given the ZANTAC EFFERDOSE trademark a serial number of 85458611. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 19, 2021. This trademark is owned by Boehringer Ingelheim Pharmaceuticals, Inc.. The ZANTAC EFFERDOSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances, namely, pharmaceutical preparations for the treatment and/or alleviation of ulcers and gastrointestinal disorders
zantac efferdose

General Information

Serial Number85458611
Word MarkZANTAC EFFERDOSE
Filing DateFriday, October 28, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 19, 2021
Registration Number4568661
Registration DateTuesday, July 15, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 18, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances, namely, pharmaceutical preparations for the treatment and/or alleviation of ulcers and gastrointestinal disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 19, 2021
Primary Code005
First Use Anywhere DateWednesday, June 15, 1994
First Use In Commerce DateWednesday, June 15, 1994

Trademark Owner History

Party NameCHATTEM, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCHATTANOOGA, TN 37409
Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877
Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877
Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Trademark Events

Event DateEvent Description
Friday, February 19, 2021CANCELLED SEC. 8 (6-YR)
Monday, July 15, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, June 21, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 15, 2014REGISTERED-PRINCIPAL REGISTER
Thursday, June 12, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 11, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, June 10, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 12, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 12, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 12, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 6, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 6, 2014NON-FINAL ACTION E-MAILED
Thursday, February 6, 2014SU - NON-FINAL ACTION - WRITTEN
Saturday, January 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 3, 2014STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 13, 2013USE AMENDMENT FILED
Wednesday, November 13, 2013TEAS STATEMENT OF USE RECEIVED
Friday, January 3, 2014EXTENSION 2 GRANTED
Wednesday, November 13, 2013EXTENSION 2 FILED
Tuesday, December 31, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 13, 2013TEAS EXTENSION RECEIVED
Saturday, May 11, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 9, 2013EXTENSION 1 GRANTED
Thursday, May 9, 2013EXTENSION 1 FILED
Thursday, May 9, 2013TEAS EXTENSION RECEIVED
Tuesday, November 13, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 18, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 18, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 29, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 14, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 14, 2012ASSIGNED TO LIE
Friday, August 3, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 2, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 2, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 2, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 22, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 22, 2012NON-FINAL ACTION E-MAILED
Wednesday, February 22, 2012NON-FINAL ACTION WRITTEN
Thursday, February 16, 2012ASSIGNED TO EXAMINER
Tuesday, November 1, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 1, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

efferdose zantac pharmaceutical preparations gastrointestinal disorders ulcers treatment substances namely alleviation